Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133(+) cells in ischemic refractory cardiomyopathy trial (RECARDIO)

BACKGROUND: Cell therapy with bone marrow (BM)-derived progenitors has emerged as a promising therapeutic for refractory angina (RA) patients. In the present study, we evaluated the safety and preliminary efficacy of transcatheter delivery of autologous BM-derived advanced therapy medicinal product...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassetti, Beatrice, Carbucicchio, Corrado, Catto, Valentina, Gambini, Elisa, Rurali, Erica, Bestetti, Alberto, Gaipa, Giuseppe, Belotti, Daniela, Celeste, Fabrizio, Parma, Matteo, Righetti, Stefano, Biava, Lorenza, Arosio, Maurizio, Bonomi, Alice, Agostoni, Piergiuseppe, Scacciatella, Paolo, Achilli, Felice, Pompilio, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137884/
https://www.ncbi.nlm.nih.gov/pubmed/30217223
http://dx.doi.org/10.1186/s13287-018-0969-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137884/
https://www.ncbi.nlm.nih.gov/pubmed/30217223
http://dx.doi.org/10.1186/s13287-018-0969-z

Ejemplares similares